IRulya Therapeutics (IRLA) Share-based Compensation (2018 - 2026)
IRulya Therapeutics' Share-based Compensation was $12.09 million in Q2 2026, up 850.0% from $1.27 million a year earlier and up 840.4% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Share-based Compensation (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, IRulya Therapeutics' Share-based Compensation was $15.83 million through Jun 30, 2026, up 222.4% year-over-year; for FY2025, it was $5.11 million, up 7.6% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $4.75 million in FY2024 (-9.1%), $5.22 million in FY2023 (-68.6%), $16.62 million in FY2022 (-44.3%) and $29.85 million in FY2021 (+106.3%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2018.
- Compared with a year earlier, Share-based Compensation was higher in six of the last eight quarters, with growth averaging 107.6%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2026 (growth of 850.0%); the worst was Q3 2022 (a decline of 90.9%).
- Per Business Quant data, IRLA's Share-based Compensation in the three quarters before Q2 2026 was $1.29 million (Q1 2026), $1.19 million (Q4 2025) and $1.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 12.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.09 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.33 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 694,000.00 |
| Jun 30, 2022 | 5.05 Mn |
| Mar 31, 2022 | 9.24 Mn |
| Dec 31, 2021 | 8.49 Mn |
| Sep 30, 2021 | 7.62 Mn |
API Access
IRulya Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();